Data from previous studies have indicated that overexpression of HER-2/neu appears to be correlated with more aggressive disease, increased metastatic potential, and poorer prognosis in patients with breast carcinoma.
CITATION STYLE
Altaha, R., Crowell, E., Hobbs, G., Higa, G., & Abraham, J. (2005, February 1). Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma. Cancer. https://doi.org/10.1002/cncr.20813
Mendeley helps you to discover research relevant for your work.